2024-10-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.75% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
9.37% |
-3.48% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.6% |
9.26% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
10.45% |
7.64% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
9.38% |
-3.37% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
9.64% |
-0.59% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.4% |
-3.09% |
2024-10-16 |
VREX
Varex Imaging Corporation
|
Buy |
9.81% |
0% |
2024-10-18 |
NKTR
Nektar Therapeutics
|
Buy |
9.81% |
0% |
2024-10-18 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.81% |
0% |
2024-10-18 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RDNT |
Sell
All
|
-3.2% |
Assets Rebalanced
None
2024-10-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.09% |
5.52% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
9.2% |
-3.15% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.48% |
10.41% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
10.35% |
8.99% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
9.31% |
-1.95% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
9.46% |
-0.34% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
9.85% |
3.83% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.7% |
2.27% |
2024-10-16 |
The percentage of cash held in the portfolio is:
21.55%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
IRWD |
Sell
All
|
5.63% |
Assets Rebalanced
None
2024-10-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
10.07% |
3.05% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
3.9% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
9.59% |
-1.16% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
9.73% |
0.33% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
9.96% |
2.69% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
9.67% |
-0.33% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
9.72% |
0.2% |
2024-10-15 |
CDXS
Codexis, Inc.
|
Buy |
9.7% |
0% |
2024-10-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.7% |
0% |
2024-10-16 |
The percentage of cash held in the portfolio is:
11.7%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
9.93% |
0.7% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.89% |
0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
9.7% |
-0.83% |
2024-10-14 |
BKD
Brookdale Senior Living Inc.
|
Buy |
9.78% |
0% |
2024-10-15 |
ARWR
Arrowhead Pharmaceuticals, Inc.
|
Buy |
9.78% |
0% |
2024-10-15 |
VCEL
Vericel Corporation
|
Buy |
9.78% |
0% |
2024-10-15 |
RDNT
RadNet, Inc.
|
Buy |
9.78% |
0% |
2024-10-15 |
The percentage of cash held in the portfolio is:
31.35%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
9.86% |
0% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.83% |
-0.32% |
2024-10-07 |
ARDX
Ardelyx, Inc.
|
Buy |
9.79% |
0% |
2024-10-14 |
The percentage of cash held in the portfolio is:
70.52%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
9.77% |
-1.17% |
2024-10-03 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.7% |
-1.95% |
2024-10-07 |
The percentage of cash held in the portfolio is:
80.53%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-6.07% |
Assets Rebalanced
None
2024-10-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
9.88% |
0.94% |
2024-10-03 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
9.79% |
0% |
2024-10-07 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.79% |
0% |
2024-10-07 |
The percentage of cash held in the portfolio is:
70.54%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IRWD
Ironwood Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-10-03 |
The percentage of cash held in the portfolio is:
90.2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-23 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
2.48% |
Assets Rebalanced
None
2024-09-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.58% |
4.89% |
2024-09-09 |
The percentage of cash held in the portfolio is:
90.42%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVCR |
Sell
All
|
-1.16% |
Assets Rebalanced
None
2024-09-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
9.1% |
-0.17% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.67% |
6.04% |
2024-09-09 |
The percentage of cash held in the portfolio is:
81.23%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ESPR |
Sell
All
|
-2.73% |
Assets Rebalanced
None
2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.72% |
-3.83% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
9.1% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.46% |
3.45% |
2024-09-09 |
The percentage of cash held in the portfolio is:
72.71%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.92% |
27.5% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.89% |
-4.92% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
9% |
-4.54% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.18% |
-2.56% |
2024-09-09 |
The percentage of cash held in the portfolio is:
61.02%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
11.4% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
10.99% |
7.2% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
12.53% |
33.96% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.69% |
-7.1% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.68% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.49% |
0.63% |
2024-09-09 |
The percentage of cash held in the portfolio is:
49.62%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
AADI |
Sell
All
|
3.43% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.88% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.97% |
5.05% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.89% |
14.37% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.58% |
-9.84% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.29% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
8.98% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.6% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
30.81%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.69% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.03% |
5.72% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.84% |
3.44% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.94% |
-6.01% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.56% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.59% |
0% |
2024-09-06 |
The percentage of cash held in the portfolio is:
40.36%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-6.41% |
AGEN |
Sell
All
|
-8.59% |
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.75% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.21% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.67% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.82% |
3.96% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.93% |
4.69% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.44% |
-0.55% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.54% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
30.63%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
APLS |
Sell
All
|
-5.21% |
ORGO |
Sell
All
|
-4.59% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.08% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.99% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.38% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.52% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.29% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
10.5% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.3% |
-10.38% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.47% |
0% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.47% |
0% |
2024-09-04 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.64% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.57% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.34% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.37% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.39% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.58% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.77% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
10.01% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.01% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.55% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.24% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.07% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.53% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.38% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.78% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
21.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.51% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.6% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.28% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.36% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.3% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.59% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.59% |
0% |
2024-08-27 |
The percentage of cash held in the portfolio is:
30.77%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.4% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.61% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
51.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
70.6%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-12 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-4.91% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
9.14% |
-7.66% |
2024-07-29 |
The percentage of cash held in the portfolio is:
90.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
1.39% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
9.6% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
9.62% |
7.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
80.78%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
9.92% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.7% |
-3.84% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
15.87% |
57.44% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
8.95% |
-11.19% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.21% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.5% |
3.13% |
2024-07-31 |
The percentage of cash held in the portfolio is:
36.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FATE |
Sell
All
|
-12.39% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.07% |
-4.31% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
10.25% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.61% |
-3.09% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
14.77% |
48.93% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.88% |
-0.36% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.3% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.29% |
2.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
28.84%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-1.15% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.17% |
-1% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.08% |
-7.9% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
10.46% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.99% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
12.15% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.14% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.74% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.43% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
20.86%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
8.84% |
-2.61% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.35% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.68% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.56% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
10.29% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.94% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
12.21% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.95% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.59% |
0% |
2024-07-30 |
The percentage of cash held in the portfolio is:
11.59%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BKD |
Sell
All
|
4.37% |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BKD
Brookdale Senior Living Inc.
|
Buy |
10.8% |
5.69% |
2024-07-16 |
RCM
R1 RCM Inc.
|
Buy |
9.06% |
-0.19% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.4% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.86% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.28% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
10.12% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None